137 related articles for article (PubMed ID: 3080326)
1. Cooperative effects of gamma interferon and 1-alpha,25-dihydroxyvitamin D3 in inducing differentiation of human promyelocytic leukemia (HL-60) cells.
Weinberg JB; Misukonis MA; Hobbs MM; Borowitz MJ
Exp Hematol; 1986 Feb; 14(2):138-42. PubMed ID: 3080326
[TBL] [Abstract][Full Text] [Related]
2. Cooperative regulation of c-myc expression in differentiation of human promyelocytic leukemia induced by recombinant gamma-interferon and 1,25-dihydroxyvitamin D3.
Matsui T; Takahashi R; Mihara K; Nakagawa T; Koizumi T; Nakao Y; Sugiyama T; Fujita T
Cancer Res; 1985 Sep; 45(9):4366-71. PubMed ID: 3928155
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line.
Ball ED; Howell AL; Shen L
Exp Hematol; 1986 Dec; 14(11):998-1005. PubMed ID: 3096754
[TBL] [Abstract][Full Text] [Related]
4. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
Nakamaki T; Kawakami K; Sato S; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
Anticancer Res; 1992; 12(5):1331-7. PubMed ID: 1444189
[TBL] [Abstract][Full Text] [Related]
5. Requirement of differentiative signals of both interferon-gamma and 1,25-dihydroxyvitamin D3 for induction and secretion of interleukin-1 by HL-60 cells.
Spear GT; Paulnock DM; Helgeson DO; Borden EC
Cancer Res; 1988 Apr; 48(7):1740-4. PubMed ID: 2832052
[TBL] [Abstract][Full Text] [Related]
6. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
7. Recombinant gamma-interferon and lipopolysaccharide enhance 1,25-dihydroxyvitamin D3-induced cell differentiation in human promyelocytic leukemia (HL-60) cells.
Murao SI; Fukumoto Y; Katayama M; Maeda H; Sugiyama T; Huberman E
Jpn J Cancer Res; 1985 Jul; 76(7):596-602. PubMed ID: 3928556
[TBL] [Abstract][Full Text] [Related]
8. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition and differentiation in HL-60 leukemia cells induced by 1,25-dihydroxyvitamin D3 and tumor necrosis factor alpha.
Wang SY; Chen LY; Wang SJ; Lin CK; Ho CK
Exp Hematol; 1991 Nov; 19(10):1025-30. PubMed ID: 1915703
[TBL] [Abstract][Full Text] [Related]
10. Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol).
Ball ED; Guyre PM; Glynn JM; Rigby WF; Fanger MW
J Immunol; 1984 May; 132(5):2424-8. PubMed ID: 6425403
[TBL] [Abstract][Full Text] [Related]
11. Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60.
Harris PE; Ralph P; Gabrilove J; Welte K; Karmali R; Moore MA
Cancer Res; 1985 Jul; 45(7):3090-5. PubMed ID: 2988760
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumor necrosis factor: synergistic actions with interferon-gamma and 1,25-dihydroxyvitamin D3.
Weinberg JB; Larrick JW
Blood; 1987 Oct; 70(4):994-1002. PubMed ID: 2820533
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation of human myeloid cell lines by tumor necrosis factor in cooperation with 1 alpha,25-dihydroxyvitamin D3.
Trinchieri G; Rosen M; Perussia B
Cancer Res; 1987 May; 47(9):2236-42. PubMed ID: 3471323
[TBL] [Abstract][Full Text] [Related]
14. Development of the cell contact-mediated accessory function for T-cell proliferation in a human promyelocytic leukaemia cell line, HL-60, by 1,25-dihydroxyvitamin D3.
Shinbori T; Yamada M; Kakimoto K; Araki S; Onoue K
Immunology; 1992 Apr; 75(4):619-25. PubMed ID: 1350568
[TBL] [Abstract][Full Text] [Related]
15. Evidence of intracellular and trans-acting differentiation-inducing activity in human promyelocytic leukemia HL-60 cells: its possible involvement in process of cell differentiation from a commitment step to a phenotype-expression step.
Okazaki T; Kato Y; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1988 Feb; 134(2):261-8. PubMed ID: 3162239
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of long-chain (sphingoid) bases on the monocytic differentiation of human leukemia (HL-60) cells induced by phorbol esters, 1 alpha, 25-dihydroxyvitamin D3, or ganglioside GM3.
Stevens VL; Winton EF; Smith EE; Owens NE; Kinkade JM; Merrill AH
Cancer Res; 1989 Jun; 49(12):3229-34. PubMed ID: 2720676
[TBL] [Abstract][Full Text] [Related]
18. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.
Gullberg U; Nilsson E; Einhorn S; Olsson I
Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582
[TBL] [Abstract][Full Text] [Related]
19. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells.
Hickstein DD; Smith A; Fisher W; Beatty PG; Schwartz BR; Harlan JM; Root RK; Locksley RM
J Immunol; 1987 Jan; 138(2):513-9. PubMed ID: 2947951
[TBL] [Abstract][Full Text] [Related]
20. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
Sokoloski JA; Shyam K; Sartorelli AC
Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
